Compound Detail
CHEMBL15192
LAPACHONE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL15192 |
| Name | LAPACHONE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | QZPQTZZNNJUOLS-UHFFFAOYSA-N |
47
Targets
137
Activities
3
Assay Types
4
PK Parameters
20
Publications
11
Known Names
3
Indications
Molecular Properties
242.3
MW (Da)
2.75
ALogP
3
HBA
0
HBD
43.4
PSA (Ų)
0.66
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Neoplasms Neoplasms Carcinoma
Activity Summary
IC50 129 meas. best 8.13
Ki 5 meas. best 7.0
EC50 3 meas. best 5.95
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| DU-145 CHEMBL613508 | IC50 | 8.13 | 8.13 | 7.4 | 1 |
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | Ki | 7.0 | 7.0 | 100.0 | 2 |
| Cocaine esterase CHEMBL3180 | Ki | 6.96 | 6.96 | 109.0 | 1 |
| Thiosulfate sulfurtransferase CHEMBL4295835 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| MDA-MB-435 CHEMBL614697 | IC50 | 6.6 | 6.6 | 250.0 | 3 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.6 | 5.9325 | 250.0 | 16 |
| HL-60 CHEMBL383 | IC50 | 6.57 | 5.942 | 270.0 | 5 |
| LoVo CHEMBL614721 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| Leptomonas seymouri CHEMBL612917 | IC50 | 6.4 | 6.4 | 400.0 | 1 |
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 6.36 | 6.216 | 440.0 | 5 |
| RAW264.7 CHEMBL612557 | IC50 | 6.33 | 5.86 | 470.0 | 2 |
| MCF7 CHEMBL387 | IC50 | 6.3 | 6.1833 | 500.0 | 3 |
| GroEL/GroES CHEMBL4106139 | IC50 | 6.23 | 6.06 | 590.0 | 2 |
| SK-MEL-28 CHEMBL614919 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 6.21 | 6.21 | 610.0 | 1 |
| Leishmania infantum CHEMBL612848 | IC50 | 6.17 | 6.06 | 670.0 | 2 |
| HaCaT CHEMBL614392 | IC50 | 6.16 | 6.0775 | 700.0 | 4 |
| MOLT-4 CHEMBL614177 | IC50 | 6.11 | 6.11 | 780.0 | 1 |
| 1A9 CHEMBL614075 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
| A549 CHEMBL392 | IC50 | 6.1 | 5.3327 | 800.0 | 15 |
| HCT-8 CHEMBL613510 | IC50 | 6.08 | 6.08 | 830.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 6.06 | 6.035 | 870.0 | 2 |
| SF-295 CHEMBL614908 | IC50 | 6.04 | 6.035 | 910.0 | 4 |
| Tyrosyl-DNA phosphodiesterase 2 CHEMBL2169736 | IC50 | 6.01 | 6.01 | 970.0 | 1 |
| KB CHEMBL398 | IC50 | 6.0 | 5.89 | 1000.0 | 3 |
| PC-3 CHEMBL390 | EC50 | 5.95 | 5.95 | 1130.0 | 1 |
| OVCAR-8 CHEMBL612555 | IC50 | 5.94 | 5.94 | 1160.0 | 2 |
| Mucosa-associated lymphoid tissue lymphoma translocation protein 1 CHEMBL3632452 | IC50 | 5.92 | 5.82 | 1200.0 | 2 |
| Liver carboxylesterase 1 CHEMBL2265 | Ki | 5.91 | 5.91 | 1220.0 | 1 |
| Leishmania amazonensis CHEMBL612877 | IC50 | 5.86 | 5.7 | 1390.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.86 | 5.6967 | 1390.0 | 3 |
| HOS CHEMBL614736 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| K562 CHEMBL385 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.78 | 5.78 | 1650.0 | 1 |
| PC-3M CHEMBL4296484 | IC50 | 5.74 | 5.74 | 1820.0 | 1 |
| A549/TR CHEMBL4483226 | IC50 | 5.72 | 5.34 | 1900.0 | 2 |
| OVCAR-3 CHEMBL614213 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| HSP60/HSP10 CHEMBL4106131 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| PBMC CHEMBL613107 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.55 | 5.55 | 2830.0 | 1 |
| Lysine-specific demethylase 4E CHEMBL1293226 | IC50 | 5.52 | 5.52 | 3000.0 | 2 |
| NAD(P)H dehydrogenase [quinone] 1 CHEMBL3623 | IC50 | 5.52 | 5.495 | 3000.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.5 | 5.0988 | 3162.3 | 8 |
| Lysine-specific demethylase 4E CHEMBL1293226 | Ki | 5.45 | 5.45 | 3550.0 | 1 |
| Nuclear factor NF-kappa-B complex CHEMBL2094258 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| A549 CHEMBL392 | EC50 | 5.38 | 5.38 | 4210.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 5.34 | 5.0933 | 4540.0 | 3 |
| NCI-H596 CHEMBL612256 | IC50 | 5.3 | 4.8367 | 5060.0 | 3 |
| MCF7 CHEMBL387 | EC50 | 5.0 | 5.0 | 9960.0 | 1 |
| NADPH--cytochrome P450 reductase CHEMBL2169731 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 114.0 | L/hr/m2 | Homo sapiens |
| F | 15.5 | % | Homo sapiens |
| T1/2 | 0.4 | hr | Mus musculus |
| T1/2 | 2.45 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine